MedTrace Logo

Vitamin D Effect on Subarachnoid Hemorrhage

NCT03482843 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 16

Last updated 2018-03-29

No results posted yet for this study

Summary

Vitamin D has been promoted to vascular regeneration in non-cerebral arteries because of its anti-inflammatory properties. Cerebral vasospasm (CVS) as the most feared complication after subarachnoid hemorrhage (SAH), correlated with higher mortality and poor outcome, is the result of a multifactorial mechanism with inflammation as one of the main role players. The investigators therefore hypothesized that vitamin D attenuates cerebral vasospasm and increases the chance for favorable outcome after SAH.

Conditions

  • Vitamin D Deficiency

Sponsors & Collaborators

  • Institut für Kardiovaskuläre Physiologie, Vascular Research Center

    collaborator UNKNOWN

  • University Clinic Frankfurt

    lead OTHER

Principal Investigators

  • Juergen Konczalla, Prof. · Goethe University Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-02-01
Primary Completion
2017-12-31
Completion
2019-12-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03482843 on ClinicalTrials.gov